HEENT Flashcards

1
Q

Diagnostics for Eye Problems

A

History: Thorough evaluation of the problem and past medical history. These helps identify any disease that may have visual problems associated with it.

Visual Acuity and ocular exam: Every Visit!

Culture and sensitivity if drainage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Eye Problems: When to Make Referral?

A

• Visual loss

• Moderate to severe pain

• Chronic eye redness

• Corneal involvement

• Unresponsive to conventional treatment after a month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blepharitis: Nonulcerative

A

Form associated with seborrhea

• Occasionally seen in those with Trisomy 21 Down’s syndrome

• Tends to affect people with psoriasis, seborrhea, eczema, allergies, and lice infestations

• Contributing factors: exposure to chemical or environmental irritants, use of eye makeup and contact lenses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blepharitis: Ulcerative

A

• Involves the lash follicle and the meibomian glands of the eyelid

• May be pustules at the base of the hair follicles that may crust and bleed

• Lashes become thin and break easily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hordeolum (stye)

A

an acutely presenting, erythematous, tender (painful) lump within the eyelid

• External hordeolum: inflammation/infection of the eyelid margin affecting the hair follicles of the eyelashes

• Internal hordeolum: inflammation/infection of the meibomian glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chalazion

A

• A granulomatous infection of a meibomian gland, presenting in the form of painless swelling on the eyelid

• Initially may be tender and erythematous before evolving into a nontender lump

• Blepharitis is frequently associated with chalazia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment for Blepharitis, Hordeolum, Chalazion

A

• Warm Compresses (teach technique)

• Gentle massage for hordeolum/chalazion

• Consider cephalexin for recurrent hordeolum

• Bacitracin or erythromycin 0.5% ointment blepharitis

• Erythromycin or Ciprofloxin for hordeolum

• Alternative: Sulfacetamide

• Oral doxycycline for sever blepharitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dry Eye

A

• Decreased tear production

• May be acquired or congenital

• Acquired disorders may be systemic
• Sjögren’s syndrome (an autoimmune disease, dry mouth and dry eye are usually first symptoms.)
• May reflect a more local infectious process, as in some forms of conjunctivitis
• May be related to trauma, such as in facial nerve (cranial nerve [CN] VII) palsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dry Eye: Causes

A

• Certain medications: anticholinergic agents, beta-adrenergic blockers, and antihistamines

• Aging, especially women during menopause

• May also have a diminished blink rate due to working at a computer or a microscope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dry Eye: Subjective and Objective Data

A

• C/O “a feeling of sand in the eyes”. Eyes feel hot, irritated and gritty

• Objective: May have no physical findings or may have a finding that causes the dry eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dry Eye: Treatment

A

Four levels of treatment depending on severity

• Level 1: education, environmental, and dietary modifications
• Elimination of offending systemic medications
• Use of artificial tear substitutes, lubricants, gels, and ointments
• Possibly eyelid therapy (see link)

• Level 2: treatment (if prior level not effective)
• Ocular lubricants, nonpreserved artificial tear substitutes, and anti-inflammatory agents such as topical cyclosporine A,
topical corticosteroids, or topical/systemic omega-3 fatty acids
• Cyclosporine ophthalmic emulsion (RESTASIS®) for chronic dry eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dry Eye: Treatment (con’t)

A

• Level 3: treatment (when levels 1 and 2 fail)
• Autologous serum, special contact lenses, and permanent punctual occlusion

• Level 4: treatment (when all else fails)
• Systemic anti-inflammatory agents
• Surgical interventions
• To correct abnormalities of the lid
• Grafting of mucous membranes
• Transplantation of a salivary gland duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Red Eye/Conjunctivitis

A

Inflammation of the conjunctiva covering the front of the eye. (Itching, watering, and redness of the eye)

Causes:
• Infectious agents: bacterial, viral, or fungal (staph aureaus, strep pneumoniae, Haemophilus influenzae
• Toxicity (from an inciting agent of some sort)
• Allergy
• Foreign body
• See page 275 for different types of conjunctivitis
• Discharge: purulent, thick with crusted lids is bacterial:
• Stringy mucoid is allergic: viral has watery discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Red Eye/Conjunctivitis

A

Inflammation of the conjunctiva covering the front of the eye. (Itching, watering, and redness of the eye)

Causes:
• Infectious agents: bacterial, viral, or fungal (staph aureaus, strep pneumoniae, Haemophilus influenzae
• Toxicity (from an inciting agent of some sort)
• Allergy
• Foreign body
• Discharge: purulent, thick with crusted lids is bacterial:
• Stringy mucoid is allergic: viral has watery discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Conjunctivitis: Diagnostic Tests

A

•USE GLOVES when examining eyes

•Check visual acuity first

•Dilated pupil exam for proptosis, optic nerve dysfunction, decreased visual acuity, diplopia, or anterior chamber inflammation (refer if this is needed)

•Using a blue penlight
• Fluorescein staining to rule out corneal involvement or keratitis
• Blue penlight illumination to see corneal scratches, corneal dendrites, or corneal ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Red Eye/Conjunctivitis: Allergic

A

Allergic
• Mast Cell Stabilizers (cromolyn sodium ophthalmic solution, Lodaxamide 0.1%) and antihistamines (Azelastine, Olopatadine)
• With allergic Acular can be used which is a topical solution
• Antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Red Eye/Conjunctivitis: Bacterial/Chlamydial

A

• Antibiotics (ointments or solutions) Erythromycin, Trimethoprim/polymixin B sulphate

• Chlamydial: add oral antibiotics

• Worsening or no improvement with excessive purulent d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Red Eye/Conjunctivitis: Viral

A

• No antibiotics.

• Use antivirals, systemic or topical (Trifluridine)
• Oral trifluidine, valacyclovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cataracts

A

An opacity of the natural lens of the eye

• 90 percent of cataracts are age-related

• Other causes of cataracts: congenital, metabolic, and traumatic etiologies

• Excessive exposure to sunlight (ultraviolet B rays) without protective lenses over time

• In the U.S., cataract surgery is the most common surgical procedure performed under Medicare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cataracts: Subjective/Objective Findings

A

• Maybe visual changes

• Gradual, painless progressive loss of vision

• May be able to visualize an opacity

• Refer to an ophthalmologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Glaucoma

A

• Progressive damage to the optic nerve, resulting in optic nerve atrophy and blindness, most typically associated with elevated intraocular pressure

• Primary or secondary (associated with an ocular condition or a systemic process)

• A congenital form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Glaucoma: Open-angle

A

• Physical diagnosis of chronic open-angle relies on evaluation of the angle by an ophthalmologist.

• Slow, PAINLESS bilateral peripheral vision loss and poor night vision), seeing halos around lights

• Treatment
• Pharmacologic
• Beta-blockers : timolol, betaxolol,
• Prostaglandin analogs: Bematoprost, latanoprost
• Laser or surgical treatment if not controlled by medication. Laser therapy is often effective only in the first several years
after surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Glaucoma: Angle-closure

A

(Closed-angle, or Narrow-angle glaucoma)

• ACUTE rapid onset with unilateral PAIN and pressure, blurred vision, seeing halos around lights, and photophobia, followed by loss of peripheral vision and then central vision loss. May have headache, n & v.

• Angle-closure glaucoma EMERGENCY

• Medications during the acute attack to lower intraocular pressure

• Acetazolamide (Diamox)

• IV mannitol with a topical miotic such as pilocarpine

• Laser iridotomy or peripheral iridectomy

• Bedrest should be maintained until the attack is broken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diabetic Retinopathy

A

• Subjective: visual changes

• Objective: changes on funduscopic exam

• Microaneurysms, intraretinal hemorrhage, macular edema, and lipid deposits

• Nerve fiber layer infarctions (“cotton wool” spots), venous beading and dilation, edema, and, in some cases, extensive retinal hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Diabetic Retinopathy (con’t)

A

• Ophthalmologist must do yearly retinal eye exam on all diabetics

• Visual changes as the disease progresses.

• Through ophthalmoscope microaneurysms, intraretinal hemorrhage, macular edema and lipid deposits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Diabetic Retinopathy: Management

A

•First goal for patients at risk for microvascular complications, including diabetic retinopathy, is prevention

•The only pharmacologic agent found to slow the progression of diabetic retinopathy is Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor

•Laser surgery for patients with proliferative diabetic retinopathy or clinically significant macular edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Macular Degeneration

A

•Leading cause of blindness in patients older than 60

•“Dry”: a slow progressive atrophy and degeneration of the retina

•“Wet”: age-related; new blood vessels develop under the retina in the macula, causing a sudden distortion or loss of central vision

• Refer immediately to an ophthalmologist

• Objective: If vision is less than 20/20, do “pinhole” test
• Vision that corrects with the pinhole test implies an uncorrected refractive error

• Possible unreactive pupil if acute angle-closure glaucoma

• Funduscopic exam is normal in patients with refractive errors
• Yellow round spots (drusen): indicative of early macular degeneration
• Clumps of pigment irregularly interspersed with depigmented areas of atrophy in the macula: later phase of the disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Pinhole Test

A

A quick way to differentiate between the two is by performing the “Pinhole Test”.

• Take a piece of card and perforate it with a pen tip, creating a pinhole about 2mm in diameter.

• Checking one eye at a time, look at an object that appears slightly blurred.

• Then look at the same object through the pinhole. If it appears sharper through the pinhole, you probably have a focusing problem.

• If it does not appear sharper, or looks even more blurred, you should refer this patient to an ophthalmologist immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Macular Degeneration: Management

A

•No proven strategies for preventing AMD

•No treatments for the initial stage of early disease

•In the intermediate stage of the disease, high-dose antioxidant vitamins and zinc supplements possibly help

•Thermal laser photocoagulation for certain forms of wet AMD but of limited value for lesions in the central macula area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Sensorineural Hearing Loss

A

Lesion in the organ of Corti or in the central pathways (including the 8th cranial nerve.

•Forms of sensorineural loss:
• Age related (presbycusis) is a form
• Meniere’s Disease
• Tumors
• Ototoxicity

30
Q

Conductive Hearing Loss

A

• Involves the outer and middle ear.

• Causes:
• Cerumen impaction
• Perforation of the tympanic membrane
• Middle ear fluid
• Trauma or infection
• Cholesteatoma (a type of skin cyst in the middle ear.

31
Q

Testing for Hearing Loss

A

Rinne Test: Normal AC twice as long as BC
• Conductive hearing loss: BC is heard longer than or equal to AC
• Sensorineural: AC is heard longer than BC in affected ear but less than 2:1 ratio

Weber Test: Normal = Symmetrical
• Sound localizes toward the poor ear with a conductive loss
• Sound localizes toward the good ear with a sensorineural loss

32
Q

Tinnitus

A

Person hears noise when there isn’t any
• Intermittent, continuous, or pulsatile (synchronous with heartbeat); may be bilateral or unilateral

Risk factors:
• Hearing loss, labyrinthitis, Ménière’s disease, otitis media or externa, otosclerosis, ear-canal blockage (from ear wax or a
foreign body)
• History of high or low blood pressure, head trauma, anemia, hypothyroidism, hyperthyroidism, or allergies
• Chronic exposure to noise
• Medications with reversible effects: salicylates, quinine, alcohol, and indomethacin [Indocin]) with reversible effects
• Medications with irreversible effects: kanamycin, streptomycin, gentamicin, and vancomycin

33
Q

Tinnitus: Management

A

• Elimination of possible offending medications (such as aspirin-containing products and NSAIDs) is a priority

• Learning to cope with tinnitus is necessary

• Avoidance of risk factors

• Possible supplementation with vitamin A, vitamin C, cyanocobalamin, and nicotinic acid or with magnesium or copper

• Protective earplugs

• Tinnitus-masking devices

• Oral antidepressants may be effective (Elavil)

• Referral to an audiologist or if vertigo, N & V to an otorhinolaryngologist

34
Q

Meniere’s Disease

A

Inner ear problem with excess fluid and pressure

• Tinnitis, vertigo, and progressive hearing loss

• Attacks can be disabling

• Must exclude other causes of vertigo

• Weber’s test will lateralize to the unaffected ear

• Basic diagnostic testing: audiogram, MRI (R/O CNS lesions), TSH

35
Q

Meniere’s Disease: Management

A

• Referral to otolaryngologist

• Low salt diet and a diuretic

• Avoid alcohol, caffeine, stress, and nicotine

• Identify and avoid triggers

36
Q

Otitis Externa (Swimmer’s Ear)

A

• Inflamed external ear canal usually unilateral

• Objective findings: Pain when pulling on the tragus

• May culture drainage

• NSAIDS and cleaning and drying the ear canal

• Staph (yellow, crust exudate) may be treated with antibiotic-hydrocortisone compound such as polymyxin B sulfate, neomycin,
hydrocortisone) Cortisporin Otic Suspension

• If aquatic sports consider coverage against Pseudomonas aeruginosa and Staphylococcus aureus

• Ciprofloxacin-hydrocortisone or ofloxacin otic solution

37
Q

Otitis Externa (Swimmer’s Ear): Complications

A

• Severe disease (preauricular or auricular cellulitis and/or fever)

• Consider dual therapy with both topical and systemic antibiotics.

• Systemic treatment with a fluoroquinolone (levofloxacin 500 mg orally once daily for seven days) for coverage of S. aureus and P. aeruginosa is preferred.

• Malignant Otitis Externa usually in diabetics or immunocompromised patients: severe pain, necrosis and osteomyelitis

• REFER and admit!! Life Threatening

38
Q

Otitis Media (OM)

A

• Otitis media with effusion (OME): transudation of plasma from middle ear blood vessels, leading to chronic effusion in the absence of the signs and symptoms of acute infection. The most significant precipitating event leading to OM with effusion is a viral upper respiratory infection

• Acute otitis media (AOM): suppurative OM or purulent OM

• Recurrent OM: the clearance of middle ear effusions between acute episodes of otic inflammation

• Chronic OM: inflammation persists more than 3 months, typically related to tympanic membrane perforation with either intermittent or persistent otic discharge

39
Q

Acute Otitis Media (AOM): Symptoms

A

• Marked “deep” ear pain and fever

• Unilateral hearing loss

• Otic discharge

• Recent history of upper respiratory infection

• Possible dizziness (space disorientation), vertigo, tinnitus (ringing in the ears), vomiting, or nausea

40
Q

Chronic Otitis Media (OM): Symptoms

A

• History of repeated bouts of acute otitis media, followed by a period of continuous or intermittent otorrhea lasting for more than three months

• Pain is seldom a complaint, as hearing loss (related to tympanic membrane perforation) is the primary concern

41
Q

Objective Signs of Otitis Media (OM)

A

OME:
• Mucous membranes of nasal and oral cavities may be injected or
edematous
• Eardrum may be dull but usually is not bulging but fluid is in the middle
ear, and eardrum mobility typically decreases on pneumatic otoscopy

AOM:
• Tympanic membrane may be amber or yellow-orange, or may be
injected and pinkish gray to fiery red in color.
• Tympanic membrane typically full or bulging in acute cases, with absent
or obscured bony landmarks and cone light reflex

42
Q

Objective Signs of Otitis Media (OM) (con’t)

A

Chronic OM:
• A perforated, draining tympanic membrane and possibly invasive granulation tissue
• Chronic, foul-smelling otorrhea—anaerobic bacterial infection
• Chronic, grayish-yellow suppuration—cholesteatoma from the degenerative products of invasive epithelialization
• Bullae formed between layers of the tympanic membrane (bullous myringitis) caused by certain viruses or Mycoplasma pneumoniae
• Multiple perforations of the tympanic membrane are characteristic of tuberculous otitis

43
Q

Management of OM

A

• Uncomplicated cases of OM: self-limited and require no specific intervention

• May need pain relief (Table 23.2)

• Pain from OM: Ibuprofen or Acetaminophen

• The preferred antibacterial drug for the patient with AOM must be active against S. pneumoniae, nontypeable H. influenzae, and M. catarrhalis.

• Treatment of complicated or recurrent OM needed to prevent permanent anatomic changes of the middle ear and subsequent
hearing loss.

AOM: Amoxicillin: 500 mg every 8 hours OR 875 mg two times daily for 10 days

β-Lactamase–resistant: Amoxicillin-clavulanate (Augmentin): 875 mg two times daily for 10 days;
Cefixime (Suprax): 400 mg daily for 7 days

Penicillin-allergic patients: Macrolides Azithromycin (Zithromax): 500 mg on day 1, then 250 mg daily for 4 days;
Clarithromycin (Biaxin): 500 mg every 12 hours for 7 days

44
Q

Management of OME

A

• Watchful waiting with symptomatic treatment

• In OME, the majority of effusions will resolve over the course of 12 weeks, and most patients can be observed over this time period.

• In patients with substantial symptoms, offer treatment with antihistamines (for OME due to allergic rhinitis), oral decongestants, and/or nasal corticosteroids.

• If effusion persists past several months

• Referred for full nasopharyngeal evaluation to rule out obstructive pathology.

45
Q

Referral for Acute Otitis Media

A

• Concurrent vertigo or ataxia

• Failed closure of a ruptured tympanic membrane

• If symptoms worsen after 3 or 4 days of treatment

Consider:
Eustachian tube dysfunction: commonly related to seasonal allergic rhinitis or upper respiratory tract infection, is
the most important factor in the pathogenesis of middle ear infections in adults.

46
Q

Mastoiditis

A

•A suppurative infection of the mastoid cells that may occur with AOM or follow an AOM

Clinical findings:
•Concurrent or recurrent AOM
•Fever and otalgia
•Persistent otitis media unresponsive to antibiotic therapy
•Postauricular swelling
•Tenderness over mastoid bone

•REFER TO ER!

47
Q

Epistaxis (Nosebleed)

A

• Posterior bleeds are more common in the elderly

• Predisposing factors: fragile mucous membranes, nasal trauma, rhinitis, drying of the nasal mucosa, deviated septum, alcohol use,
and antiplatelet meds

48
Q

Epistaxis (Nosebleed): Examination

A

• Look for underlying conditions

• If lots of bleeding reported - CBC

• Management: Application of direct pressure to the anterior portion of the nose for a minimum of 10 min if source is
anterior.

• Sit up leaning forward

• Nasal decongestants

• Phenylephrine 0.125% (Afrin, Neo-Synephrine, Sinex)

49
Q

Rhinitis (Coryza)

A

Nasal Congestion: (2 Types) Allergic & Nonallergic

Nonallergic Rhinitis:
1. Infectious
2. Irritant-related (often in the workplace)
3. Vasomotor (noninfectious without eosinophilia)
4. Hormone-related
5. Associated with medication use or overuse (rhinitis medicamentosum)
6. Atrophic (mostly in geriatric patients)

Allergic: Seasonal or perennial (recurrent)

50
Q

Clinical Presentation of Rhinitis

A

Viral rhinitis (usually acute and self-limiting)
• Accompanied by malaise, headache, sore throat, and occasionally fever .
• If hoarseness, cough, diarrhea, conjunctivitis or viral rash. highly suggestive of viral

Allergic rhinitis: IgE mediated response
• Itching in the nasal passages, conjunctivae, and roof of the mouth
• Epiphoria (stringy, watery ocular discharge)
• Sneezing, coughing, and a sore or burning throat
• Consider pharyngitis

51
Q

Clinical Presentation of Vasomotor Rhinitis

A

Noninfectious rhinitis without eosinophilia

• Watery rhinorrhea, nasal congestion, “nasal” speech, and forced mouth-breathing

• Onset of congestion is rapid in vasomotor rhinitis; patients typically complain of a pronounced, watery postnasal drip, as well as persistent nasal obstruction that may switch sides with each attack

• Fluctuations and reductions in estrogen contribute to this type (menses, BCP, pregnancy, menopause)

52
Q

Management of Allergic Rhinitis

A

• Avoidance or reduced exposure to offending allergens

• Oral antihistamines: short-term treatment

• Intranasal corticosteroids: long-term management

• Flonase

• Leukotriene receptor antagonists

53
Q

Management of Viral Rhinitis

A

Treat symptomatically

• Fever and headache may be treated with acetaminophen

• Rhinorrhea may be treated with oral decongestants

• Topical preparations

• Intranasal ipratropium (Atrovent) nasal spray

• Dextromethorphan for persistent coughs

54
Q

Sinusitis

A
  1. Acute: abrupt onset of infection and post-therapeutic resolution of symptoms lasting no more than 4 weeks
  2. Subacute: a purulent nasal discharge persists despite therapy, lasting from 4 to 12 weeks
  3. Chronic: episodes of prolonged inflammation with repeated or inadequately treated acute infection lasting greater than 12 consecutive weeks
55
Q

Subjective Symptoms of Sinusitis

A

• Gradual onset of symptoms

• Recurrent or chronic dull, constant pain over the affected sinuses

• Criteria for treatment is that it has lasted for >7 days.

• Worsening after getting better

• Pain increases and becomes characteristically throbbing

• Sinusitis Subjective Symptom
• Maxillary : pain over the cheeks and upper teeth—may worsen when standing erect
• Frontal : pain over the eyebrows—may worsen when recumbent
• Ethmoid : pain over or behind the eyes associated with retro-orbital pain

56
Q

Objective Signs of Sinusitis

A

• Purulent nasal secretions

• Total opacification of affected sinuses on transillumination

• A swollen pale mucosa with watery secretions, points to allergic sinusitis or rhinitis

• Black or necrotic material—mucormycosis-related rhinorrhea in immunocompromised patients

• Ethmoid sinus involvement may result in chemosis (eyelid mucous membrane edema), proptosis, conjunctival injection, extraocular muscle palsy, or orbital fixation

• Tenderness on palpation over the sinuses

57
Q

Management of Sinusitis

A

• Since a vast majority of acute sinusitis cases are caused by viruses, antibiotics are largely unhelpful

• Antimicrobial therapy indicated for acute uncomplicated BACTERIAL sinusitis

• TREATMENT: Saline nasal spray; decongestant nasal spray, NSAIDS, corticosteroids

• Dedicated sinus irrigation two or more times a day

• Referral to a specialist if the patient has recurrent sinusitis, allergic sinusitis or if it is refractory to antibiotic therapy

58
Q

Management of Sinusitis (con’t)

A

• A cool-mist, ultrasonic humidifier

• Avoid smoke and other environmental pollutants

• Increase fluid intake

• Use a heated mist from a facial sauna, steam bath, shower, or hot, moist towels wrapped around the face

59
Q

Medications for Sinusitis

A

• Oral analgesics for pain

• Avoid nonprescription medicated nose drops and sprays

• Use prescription nasal sprays for no more than 3 to 4 days at a time (LIMIT AFRIN!!)

• Expectorants such as guaifenesin to liquefy sinus secretions and facilitate drainage

• Anti-inflammatory topical steroids in nasal spray preparations

• Empiric antibiotic therapy for 7 to 10 days

• Augmentin 875mg BID for 5-7 days

• If PCN allergy: Doxycycline 100mg BID or Levofloxacin 750mg daily

60
Q

Stomatitis and Glossitis

A

• Oral candidiasis

• Aphthous (canker sores)

• Secondary herpetic stomatitis

• Vincent’s stomatitis: acute necrotizing ulcerative gingivitis or trench mouth

• Allergic stomatitis

• Parasitic glossitis (black hairy tongue)

• Hairy Leukoplakia: with no other symptoms of immune suppression is strongly suggestive of HIV.

61
Q

Pharyngitis and Tonsillitis

A

• Infection/irritation of the pharynx/tonsils.

• May be noninfectious or infections

• Noninfectious: allergies, trauma (burns/foreign object), cancer, chemo, radiation, irritation

• Infectious: viruses, bacteria, fungi or parasites (strep: A, C, and G beta hemolytic)

Common causes:
• Viruses -adenovirus, rhinovirus, coxsackie virus
• Group A Beta Hemolytic Strep (GABHS)
• Mycoplasma pneumoniae in ~10% of cases in adolescents

62
Q

Group A Strep

A

• Most important to identify (responsible for acute rheumatic fever and post-strep glomerulonephritis.

• Group C is more common in college students an adolescents

Signs and Symptoms
• Viral: Most common. Sudden onset of sore throat, fever, malaise, cough, headache, myalgias and fatigue mild erythema (little or no exudate). No painful or tender lymph glands.

63
Q

Group A beta hemolytic strep (GABHS)

A

• More prevalent in kids less than 15: Sudden onset, painful swallowing, fever, chills, H/A, N & V.

• Marked erythema, patchy, discrete, white or yellow exudate. Tender ANTERIOR lymph nodes

• Use the Modified CENTOR Score

• If score above 4, treat even if no rapid strep

64
Q

Diagnostic Tests for Pharyngitis/Tonsillitis

A

• Rapid strep test for GABHS
• If rapid strep test is negative, specimen should be sent for full culture

• If symptoms suggest, consider a mono spot test

• CBC rarely indicated

65
Q

Pharyngitis/Tonsillitis: Differential Diagnoses

A

• Infectious mononucleosis (MONO):
• H/A, malaise, fatigue, and anorexia before sore throat, tender POSTERIOR lymph nodes
• Hepato-splenomegaly, and POSITIVE mono spot.

• Allergies: teary eyes, pruritus, rhititis, postnasal drip, pale, boggy nasal mucosa and erythematous pharynx with mucus

• Thrush:
• Peritonsillar cellulitis/abscess

• Pharyngeal abscess (need to send to ED or physician)
• Deviated uvula

• Reflux pharyngitis:
• GABHS
• Sinusitis

66
Q

Pharyngitis/Tonsillitis: Management

A

• No antibiotics unless strong evidence of GABHS recommended by the American College of Physicians.

• Criteria for treatment: hx of fever, exudate, palpable anterior cervical tender glands, absence of cough

• TREATMENT (10 days):
• Penicillin VK oral 500 mg po BID
• Amoxicillin 1000 mg Daily
• Cephalexin 500 mg BID

• If sever PCN allergy
• Clindamycin: 300 mg TID
• Azithromycin 500 mg Daily

67
Q

Management of Pharyngitis Viral

A

• Rest, fluids, humidification, voice rest, and warm saline gargles

• Acetaminophen or ibuprofen

• Topical anesthetic sprays and lozenges

• MONO: NO SPORTS FOR 6 WEEKS

68
Q

Pharyngitis/Tonsillitis: Education

A

• Contagious until 24 hours after start of antibiotic therapy

• Adherence to prescribed therapy

• Proper oral hygiene

• Toothbrushes and orthodontic devices should be cleaned thoroughly

• Misuse of antibiotic therapy (for viral infections)

69
Q

Temporomandibular Joint Disorder (TMD)

A

• A cluster of related disorders in the masticatory system

• The most common presenting symptom is PAIN in the muscles of mastication, the preauricular area, and/or the temporomandibular joint

• Chewing, bruxism (clenching, grinding, or gnashing of the teeth during nonfunctional movements of the mandible), or other jaw functions tend to aggravate the pain

70
Q

Subjective Symptoms of Temporomandibular Joint Disorder (TMD)

A

• Pain (89%)

• Jaw noise (85%)

• Limited jaw movement (40%)

• Ear symptoms account for 28% of clinical presentations

• Only 4% of patients present with obvious jaw dislocation

71
Q

Management of TMD

A

• Use a multidisciplinary approach

• Goals for management: reduction or elimination of pain and restoration of acceptable mandibular function

• Adjustment in diet consistency, education, and alteration of oral parafunctional habits

• Application of ice (for acute symptomatology) or moist heat (for chronic symptomatology)

72
Q

Other Treatment for TMD

A

• Physical therapy
• Electromodalities and therapeutic exercises

• Behavioral therapy
• Stress relief, pain control methods such as counseling, hypnosis, biofeedback, and guided imagery

• Pharmacotherapy
• NSAIDS